Amicus Therapeutics, Inc. (DELISTED) (FOLD:DL)
14.49
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Amicus Therapeutics Net Income (Quarterly) : 1.69M for Dec. 31, 2025
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.69M |
| September 30, 2025 | 17.31M |
| June 30, 2025 | -24.42M |
| March 31, 2025 | -21.69M |
| December 31, 2024 | 14.74M |
| September 30, 2024 | -6.729M |
| June 30, 2024 | -15.70M |
| March 31, 2024 | -48.42M |
| December 31, 2023 | -33.84M |
| September 30, 2023 | -21.58M |
| June 30, 2023 | -43.23M |
| March 31, 2023 | -52.93M |
| December 31, 2022 | -55.86M |
| September 30, 2022 | -33.29M |
| June 30, 2022 | -62.16M |
| March 31, 2022 | -85.26M |
| December 31, 2021 | -83.28M |
| September 30, 2021 | -50.29M |
| June 30, 2021 | -51.22M |
| March 31, 2021 | -65.66M |
| December 31, 2020 | -71.40M |
| September 30, 2020 | -64.01M |
| June 30, 2020 | -52.49M |
| March 31, 2020 | -88.95M |
| December 31, 2019 | -89.73M |
| Date | Value |
|---|---|
| September 30, 2019 | -61.81M |
| June 30, 2019 | -84.55M |
| March 31, 2019 | -120.30M |
| December 31, 2018 | -78.08M |
| September 30, 2018 | -159.16M |
| June 30, 2018 | -61.83M |
| March 31, 2018 | -49.92M |
| December 31, 2017 | -69.21M |
| September 30, 2017 | -111.67M |
| June 30, 2017 | -48.14M |
| March 31, 2017 | -54.99M |
| December 31, 2016 | -58.65M |
| September 30, 2016 | -46.65M |
| June 30, 2016 | -51.05M |
| March 31, 2016 | -43.69M |
| December 31, 2015 | -42.90M |
| September 30, 2015 | -37.80M |
| June 30, 2015 | -27.13M |
| March 31, 2015 | -24.29M |
| December 31, 2014 | -21.22M |
| September 30, 2014 | -17.15M |
| June 30, 2014 | -14.61M |
| March 31, 2014 | -15.94M |
| December 31, 2013 | -12.24M |
| September 30, 2013 | -14.59M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 44.76M |
| Insmed, Inc. | -13.24M |
| Ligand Pharmaceuticals, Inc. | 48.51M |
| PTC Therapeutics, Inc. | 83.50M |
| Establishment Labs Holdings, Inc. | -11.75M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 185.21M |
| Total Expenses (Quarterly) | 183.52M |
| EPS Diluted (Quarterly) | 0.0054 |
| Enterprise Value | 4.699B |
| Gross Profit Margin (Quarterly) | 84.64% |
| Profit Margin (Quarterly) | 0.91% |
| Earnings Yield | -0.61% |
| Operating Earnings Yield | 0.77% |
| Normalized Earnings Yield | -0.5845 |